ACRIVON THERAPEUTICS INC (ACRV) Stock Analyst Earnings Estimates
NASDAQ:ACRV - Nasdaq - US0048901096 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 1,037.93% | N/A 659.30% | N/A 253.22% | N/A 143.52% | N/A 55.09% | N/A 38.18% | N/A 39.49% | ||||||
| EBITDA YoY % growth | -3.16M | -16.14M -410.76% | -32.3M -100.12% | -66.567M -106.09% | -88.193M -32.49% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.17M | -16.18M -410.41% | -32.66M -101.85% | -67.103M -105.46% | -89.199M -32.93% | N/A -7.98% | N/A -21.20% | N/A -21.42% | N/A 1.07% | N/A 20.61% | N/A 60.18% | N/A 240.63% | N/A 118.69% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.73 60.91% | -2.44 10.62% | N/A 5.33% | N/A -4.33% | N/A 1.23% | N/A -7.12% | N/A 22.30% | N/A 61.00% | N/A 171.29% | N/A 250.00% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 -15.00% | -0.60 -1.70% | -0.58 3.06% | -0.67 -31.93% |
| Revenue Q2Q % growth | 147.9K | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.372M -9.02% | -24.087M 4.19% | -25.011M -0.23% | -27.007M -24.67% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.51 30.14% | -0.66 | 0.15 | 22.15% |
| Q4 2024 Q2Q % growth | -0.60 30.23% | -0.68 | 0.08 | 11.91% |
| Q3 2024 Q2Q % growth | -0.59 10.61% | -0.59 | 0.00 | -0.13% |
| Q2 2024 Q2Q % growth | -0.52 17.46% | -0.61 | 0.09 | 15.33% |
| Q1 2024 Q2Q % growth | -0.73 -25.86% | -0.86 | 0.13 | 15.28% |
| Q4 2023 Q2Q % growth | -0.86 -7.50% | -0.74 | -0.12 | -15.99% |
| Q3 2023 Q2Q % growth | -0.66 | -0.72 | 0.06 | 8.67% |
| Q2 2023 Q2Q % growth | -0.63 | -0.66 | 0.03 | 4.77% |
| Q1 2023 Q2Q % growth | -0.58 | -0.61 | 0.03 | 5.27% |
| Q4 2022 Q2Q % growth | -0.80 | -1.12 | 0.32 | 28.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 10.61% | 1.82% | 15.71% |
| Revenue | N/A | N/A | 0% | -12.5% |